130 related articles for article (PubMed ID: 22873040)
21. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
22. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2008 Sep; 15(9):2482-6. PubMed ID: 18612697
[TBL] [Abstract][Full Text] [Related]
23. A retrospective analysis of prognostic factors predictive of lymph-node metastasis and recurrence in thyroid papillary microcarcinoma.
Usluogullari CA; Onal ED; Ozdemir E; Ucler R; Kiyak G; Ersoy PE; Yalcin S; Güler G; Ersoy R; Cakir B
Minerva Endocrinol; 2015 Mar; 40(1):15-22. PubMed ID: 24699706
[TBL] [Abstract][Full Text] [Related]
24. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection.
Wada N; Duh QY; Sugino K; Iwasaki H; Kameyama K; Mimura T; Ito K; Takami H; Takanashi Y
Ann Surg; 2003 Mar; 237(3):399-407. PubMed ID: 12616125
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.
Zhang L; Wei WJ; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1250-7. PubMed ID: 22319042
[TBL] [Abstract][Full Text] [Related]
26. [Prospective analysis of the risk factors and clinical indications of dissection of lymph node posterior to right recurrent laryngeal nerve in 283 cases of papillary thyroid carcinoma].
Zhang P; Zhang B; Bu J; Liu Y; Zhang W
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):109-14. PubMed ID: 24796458
[TBL] [Abstract][Full Text] [Related]
27. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
28. Features Predictive of Distant Metastasis in Papillary Thyroid Microcarcinomas.
Jeon MJ; Kim WG; Choi YM; Kwon H; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Kim TY; Shong YK; Song DE; Kim WB
Thyroid; 2016 Jan; 26(1):161-8. PubMed ID: 26563473
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk.
Papini E; Guglielmi R; Gharib H; Misischi I; Graziano F; Chianelli M; Crescenzi A; Bianchini A; Valle D; Bizzarri G
Thyroid; 2011 Aug; 21(8):917-20. PubMed ID: 21595556
[TBL] [Abstract][Full Text] [Related]
31. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
32. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
33. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
[TBL] [Abstract][Full Text] [Related]
34. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
35. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
Xu Y; Xu L; Wang J
J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
[TBL] [Abstract][Full Text] [Related]
36. Patterns and predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma.
Kim YS
Otolaryngol Head Neck Surg; 2012 Jul; 147(1):15-9. PubMed ID: 22399280
[TBL] [Abstract][Full Text] [Related]
37. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M
Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182
[TBL] [Abstract][Full Text] [Related]
38. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
[TBL] [Abstract][Full Text] [Related]
39. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
[TBL] [Abstract][Full Text] [Related]
40. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
